[1]Blandin Knight S, Crosbie PA, Balata H, et al. Progress and prospects of early detection in lung cancer\[J\]. Open Biol, 2017, 7(9):170070.
[2]Feng Y, Gao Y, Yu J, et al. CCDC85B promotes nonsmall cell lung cancer cell proliferation and invasion\[J\]. Mol Carcinog, 2019, 58(1):126-134.
[3]李海燕,王保健. 青年肺癌患者临床特征及发病相关因素分析\[J\]. 实用预防医学, 2020, 27(6):699-703.
[4]辛艳芳, 李梅,曹倍辈. 2012~2017年武汉市汉阳区恶性肿瘤发病与死亡特征分析\[J\]. 预防医学论坛, 2019, 25(7):525-528.
[5]LemjabbarAlaoui H, Hassan OU, Yang YW, et al. Lung cancer: Biology and treatment options\[J\]. Biochim Biophys Acta, 2015, 1856(2):189-210.
[6]Duma N, SantanaDavila R, Molina JR. Nonsmall cell lung cancer: epidemiology, screening, diagnosis, and treatment\[J\]. Mayo Clin Proc, 2019, 94(8):1623-1640.
[7]Hirsch FR, Scagliotti GV, Mulshine JL, et al. Lung cancer: current therapies and new targeted treatments\[J\]. Lancet, 2017, 389(10066):299-311.
[8]Cassidy A, Minihane AM. The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids\[J\]. Am J Clin Nutr, 2017, 105(1):10-22.
[9]姜泽群, 李沐涵, 马艳霞, 等. 木犀草素通过上调microRNA34a5p诱导肺癌细胞株H460凋亡的研究\[J\]. 天然产物研究与开发, 2018, 30(2):169-175.
[10]Majumdar D, Jung KH, Zhang H, et al. Luteolin nanoparticle in chemoprevention:in vitro and in vivo anticancer activity\[J\]. Cancer Prev Res (Phila), 2014, 7(1):65-73.
[11]Li J, Cheng X, Chen Y, et al. Vitamin E TPGS modified liposomes enhance cellular uptake and targeted delivery of luteolin: An in vivo/in vitro evaluation\[J\]. Int J Pharm, 2016, 512(1):262-272.
[12]刘雅茹, 吴孟霏,孙玉琦. 载姜黄素的胆固醇透明质酸聚合物胶束的制备及评价\[J\]. 中国医药工业杂志, 2020, 51(5):613-619.
[13]孙晓峰, 刘涛, 凌芸, 等. 透明质酸修饰纳米胶束用于靶向肿瘤治疗及药物释放行为的研究进展\[J\]. 中国药科大学学报, 2019, 50(6):641-647. |